What is the recommended dose of cefdinir (Cephalosporin) for treating acute otitis media in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosing for Acute Otitis Media in Adults

For adults with acute otitis media, cefdinir should be administered at a dose of 300 mg twice daily or 600 mg once daily for 10 days.

Recommended Dosing

  • Cefdinir can be administered as either 300 mg twice daily or 600 mg once daily for acute otitis media in adults 1, 2
  • The total daily dose should not exceed 600 mg 2
  • Treatment duration should be 10 days for optimal clinical outcomes 2, 3
  • Cefdinir may be administered without regard to meals 2

Efficacy for Acute Otitis Media

  • Cefdinir is an oral third-generation cephalosporin with good activity against common otitis media pathogens, including Haemophilus influenzae, Moraxella catarrhalis, and penicillin-susceptible Streptococcus pneumoniae 3, 4
  • Clinical efficacy rates of approximately 83-88% have been reported for cefdinir in respiratory tract infections 1
  • Cefdinir distributes well into middle ear fluid, making it appropriate for otitis media treatment 4, 5

Role in Treatment Algorithm

  • While amoxicillin is recommended as first-line therapy for acute otitis media in most guidelines, cefdinir is an appropriate alternative for adults with penicillin allergy 1
  • Cefdinir is particularly valuable in areas with high rates of beta-lactamase producing organisms 3, 4
  • For patients who have received antibiotics in the previous 4-6 weeks, cefdinir may be considered as an initial therapy option 1

Special Considerations

  • For patients with renal insufficiency (creatinine clearance <30 mL/min), the dose should be reduced to 300 mg once daily 2
  • For patients on hemodialysis, 300 mg should be given every other day with an additional 300 mg dose at the conclusion of each hemodialysis session 2
  • The most common adverse effect is diarrhea, occurring in approximately 11-20% of patients 5, 6

Monitoring and Follow-up

  • If there is no clinical improvement after 72 hours of therapy, reassessment is necessary to either confirm the diagnosis or consider an alternative antibiotic 1
  • When switching antibiotics due to treatment failure, consider the limitations in coverage of the initial agent 1

Comparative Efficacy

  • In clinical trials, cefdinir has demonstrated similar efficacy to amoxicillin-clavulanate for respiratory infections including sinusitis, which has similar microbiology to otitis media 7
  • Cefdinir has shown effectiveness against beta-lactamase-producing organisms that may cause treatment failure with amoxicillin alone 3, 4

Limitations

  • Cefdinir may have limited effectiveness against penicillin-resistant Streptococcus pneumoniae strains, even at higher doses 6
  • The WHO's Essential Medicines recommendations prioritize amoxicillin and amoxicillin-clavulanate as first and second choices for otitis media, with cephalosporins not specifically recommended 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.